Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa

Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa

US Patent 12435150 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD40 antibodies for use in treatment of Sjögren's syndrome2024
Anti-CD40 antibodies for use in treatment of Sjögren's syndrome2024
Anti-CD40 antibodies for use in prevention of graft rejection2023
Anti-CD40 antibodies for use in prevention of graft rejection2023
Method of treating transplant rejection with silent Fc variants of anti-CD40 ant2021
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Methods and compositions for safe and effective treatment of erythema2018
Methods and compositions for safe and effective treatment of erythema2018
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2017
Silent Fc variants of anti-CD40 antibodies2017
Silent Fc variants of anti-CD40 antibodies2015
Methods and compositions for safe and effective treatment of telangiectasia2014